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System Design
We used data from the FAERS database to populate our TylerADE system shown in figure 2. We used the methods shown in figure 
3 to clean and prepare the data. We captured patient outcomes from FDA form 3500 shown in figure 4. Our severity is calculated by 




















Experimental Results and Discussion
We found that on average that the addition of a random adjunct to a random opioid showed no benefit. However, after looking at specific drug 
combinations, some of them showed a major increase in severity, and others showed a major decrease in severity. We made a list of the most 




















Combinations that Lowered Severity            
Opioid Severity Combination Severity
Experimental Design
Our FAERS data was from 2004 Quarter 1 to 2018 Quarter 2 as displayed in Figure 5. We build thee models to analyze our data, 
Each model was a matrix of Drug Names, Patient Deaths, ADR’s, and Demographics. The first model contained 75 adjuncts, the second model 
contained 20 opioids, and the final model contained both opioids and adjuncts as shown in figure 6. 
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Figure 4: FDA form 3500
Research Questions
▪ Does the addition of adjuncts to opioid 
prescriptions significantly impact adverse 
drug events? 
▪ Which adjunct and opioid combinations are 
most dangerous?
Introduction
Opioids are commonly used as pain relievers but can be very harmful to the people taking them. Studies have shown that opioids cause more 
deaths than car wrecks or all other drug overdoses combined as displayed in figure 1. Certain non-opioid drugs (Adjuncts) can be used to lower 
the amounts of opioids taken, and to limit addiction while maintaining effectiveness. To study which adjuncts lower the severity and which ones 
don’t, we have analyzed over 135 million records from the FDA's Adverse Event Reporting System (FAERS) dataset. The outcomes varied, but 
some of the cases were extreme. An adjunct could make the effects of one opioid less severe and make another opioid’s effects more severe. For 
example, the addition of Acetaminophen to Fentanyl lowered the reported death percentage by 28.38%, while the addition of Acetaminophen to 
Hydrocodone made the death rate 35.79% higher. 
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Conclusions
Certain adjuncts significantly lower the severity of the opioids they are taken with, while other combinations could be deadly.
Figure 2: 
TylerADE
